[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
December 1984

Platelet α2-Adrenergic Receptor Binding and Plasma CatecholaminesBefore and During Imipramine Treatment in Patients With Panic Anxiety

Author Affiliations

From the Departments of Psychiatry (Drs Cameron, Nesse, and Curtis) and Pharmacology (Drs Smith and Hollingsworth), University of Michigan Medical School, Ann Arbor.

Arch Gen Psychiatry. 1984;41(12):1144-1148. doi:10.1001/archpsyc.1984.01790230030004

• Specific binding of tritiated clonidine, an α2-adrenergic receptor agonist, and tritiated yohimbine, an α2-adrenergic receptor antagonist, to platelet membranes was measured in persons with panic attacks or major depression and in normal subjects. Plasma catecholamine levels were measured in patients with panic attacks and in normal subjects. The number of binding sites in patients with panic attacks, as measured with tritiated clonidine, was lower than in depressed persons and was the same as in normal subjects. The number in patients with panic attacks, as measured with tritiated yohimbine, was lower than in either depressives or normal subjects. Catecholamine levels were somewhat higher in patients with panic attacks than in normal subjects. Treatment with imipramine hydrochloride decreased the number of sites, as measured with either ligand, in both patient groups and increased catecholamine levels in patients with panic attacks.